Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prostaglandin E EP3 receptor (EP3 receptor) is a G protein-coupled receptor (GPCR) that binds prostaglandin E2 (PGE2), a bioactive lipid involved in numerous physiological and pathological processes. The human gene encoding this receptor is PTGER3, located on chromosome 1p31.1. Humans express at least eight isoforms of the EP3 receptor due to alternative splicing, resulting in proteins with variable C-terminal regions and diverse signaling pathways. EP3 receptor activation mediates various functions including pain modulation, negative regulation of glucose-stimulated insulin secretion, vasoconstriction, and platelet aggregation. Its role varies across diseases, with both pro-tumorigenic and anti-tumorigenic roles described in cancer.
Gi-coupled inhibition of adenylate cyclase, Gq-coupled increase in intracellular calcium, Gs-coupled increase in cAMP (isoform-dependent)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E EP3 Receptor (EP3 receptor).